Regeneron Pharmaceuticals (REGN) Insider Trading & Ownership $681.58 -11.65 (-1.68%) As of 01/17/2025 04:00 PM Eastern Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Regeneron Pharmaceuticals (NASDAQ:REGN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.48%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)10Amount OfInsider Selling(Last 12 Months)$85.04 M Get REGN Insider Trade Alerts Want to know when executives and insiders are buying or selling Regeneron Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address REGN Insider Buying and Selling by Quarter Regeneron Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/29/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$750.22$1,001 - $15,00011/19/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$744.60$1,001 - $15,00011/13/2024Jonathan L. JacksonU.S. Congress Member (D-IL)Sell$804.33$15,001 - $50,00011/1/2024Jonathan L. JacksonU.S. Congress Member (D-IL)Sell$843.60$1,001 - $15,00010/23/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$941.39$1,001 - $15,00010/15/2024Greg LandsmanU.S. Congress Member (D-OH)Sell$1,016.53$1,001 - $15,0008/28/2024Christopher R FenimoreCFOSell5,680$1,205.33$6,846,274.40 8/7/2024Jason PitofskyVPSell487$1,070.00$521,090.00 7/11/2024Joseph J LarosaEVPSell1,866$1,088.95$2,031,980.70 7/1/2024Arthur F RyanDirectorSell100$1,059.24$105,924.00 7/1/2024Marion MccourtEVPSell1,137$1,047.11$1,190,564.07 7/1/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$1,057.02$1,001 - $15,0006/24/2024Bonnie L BasslerDirectorSell756$1,062.00$802,872.00 6/14/2024Michael S BrownDirectorSell1,535$1,040.00$1,596,400.00 6/11/2024Leonard S SchleiferCEOSell9,064$1,015.43$9,203,857.52 6/6/2024Leonard S SchleiferCEOSell787$1,015.02$798,820.74 6/5/2024Bonnie L BasslerDirectorSell827$1,011.00$836,097.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 5/28/2024Michael S BrownDirectorSell1,172$974.86$1,142,535.92 5/17/2024Leonard S SchleiferCEOSell22,830$979.23$22,355,820.90 5/14/2024Leonard S SchleiferCEOSell25,000$979.25$24,481,250.00 4/4/2024Tommy TubervilleU.S. Congress Member (R-AL)Sell$937.02$1,001 - $15,0003/14/2024Andrew J MurphyEVPSell5,783$956.47$5,531,266.01 3/1/2024Arthur F RyanDirectorSell100$982.05$98,205.00 3/1/2024Marion MccourtEVPSell358$967.50$346,365.00 2/26/2024Bonnie L BasslerDirectorSell854$979.25$836,279.50 2/22/2024Joseph J LarosaEVPSell1,000$967.65$967,650.00 2/8/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$946.43$1,001 - $15,0002/7/2024Joseph J LarosaEVPSell1,000$950.00$950,000.00 2/5/2024Marion MccourtEVPSell1,000$934.71$934,710.00 2/1/2024Arthur F RyanDirectorSell100$954.22$95,422.00 1/30/2024Bonnie L BasslerDirectorSell827$959.00$793,093.00 1/23/2024Joseph L GoldsteinDirectorSell2,707$950.00$2,571,650.00 (Data available from 1/1/2013 forward) REGN Insider Trading Activity - Frequently Asked Questions Who is on Regeneron Pharmaceuticals's Insider Roster? The list of insiders at Regeneron Pharmaceuticals includes Andrew J Murphy, Arthur F Ryan, Bonnie L Bassler, Christine A Poon, Christopher R Fenimore, George L Sing, George Yancopoulos, Huda Y Zoghbi, Jason Pitofsky, Joseph J Larosa, Joseph L Goldstein, Leonard S Schleifer, Marc Tessier-Lavigne, Marion Mccourt, Michael S Brown, N Anthony Coles, Neil Stahl, Plew Daniel P Van, Robert E Landry. Learn more on insiders at REGN. What percentage of Regeneron Pharmaceuticals stock is owned by insiders? 7.48% of Regeneron Pharmaceuticals stock is owned by insiders. Learn more on REGN's insider holdings. Which Regeneron Pharmaceuticals insiders have been selling company stock? The following insiders have sold REGN shares in the last 24 months: Andrew J Murphy ($5,531,266.01), Arthur F Ryan ($841,141.00), Bonnie L Bassler ($6,458,174.50), Christine A Poon ($10,314,831.60), Christopher R Fenimore ($12,129,219.52), George Yancopoulos ($28,655,829.68), Huda Y Zoghbi ($850,000.00), Jason Pitofsky ($521,090.00), Joseph J Larosa ($3,949,630.70), Joseph L Goldstein ($5,462,050.00), Leonard S Schleifer ($56,839,749.16), Marion Mccourt ($6,981,096.57), Michael S Brown ($7,030,834.32), Neil Stahl ($9,810,031.70), Plew Daniel P Van ($5,216,076.87), and Robert E Landry ($1,496,786.36). How much insider selling is happening at Regeneron Pharmaceuticals? Insiders have sold a total of 177,160 Regeneron Pharmaceuticals shares in the last 24 months for a total of $162,087,807.99 sold. Which members of congress are trading Regeneron Pharmaceuticals? Josh Gottheimer (D-NJ), Jonathan L. Jackson (D-IL), Greg Landsman (D-OH), and Tommy Tuberville (R-AL) have sold shares of Regeneron Pharmaceuticals in the last year totaling $96,500. Regeneron Pharmaceuticals Key ExecutivesDr. Leonard S. Schleifer M.D. (Age 71)Ph.D., Co-Founder, President, CEO & Co-Chairman Compensation: $8.18MDr. George D. Yancopoulos M.D. (Age 64)Ph.D., Co-Founder, President, Chief Scientific Officer & Co-Chairman Compensation: $7.76MDr. Andrew J. Murphy Ph.D. (Age 65)Executive Vice President of Research Compensation: $1.68MMr. Daniel P. Van Plew (Age 51)Executive VP and GM of Industrial Operations & Product Supply Compensation: $2.01MMr. Christopher R. Fenimore CPA (Age 53)Senior VP of Finance & CFO 1 recent tradesMs. Patrice GiloolySenior Vice President of Quality Assurance & OperationsMr. Bob McCowanSenior VP of IT & Chief Information OfficerMr. Ryan CroweSenior Vice President of Investor Relations & Strategic AnalysisMr. Joseph J. LaRosa (Age 65)Executive VP, General Counsel & Secretary Compensation: $1.75MMs. Melissa LoznerSenior VP & Chief Compliance Officer More Insider Trading Tools from MarketBeat Related Companies AMGN Insider Transactions GILD Insider Transactions VRTX Insider Transactions ALNY Insider Transactions BIIB Insider Transactions UTHR Insider Transactions NBIX Insider Transactions INCY Insider Transactions BMRN Insider Transactions EXAS Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Strong Capital Returns and Insider Buying SignalsZymeworks in Focus for Insider Activity: Catalysts AheadInsiders Are Loading Up: 3 Key Stock Picks for InvestorsInsiders Are Selling, But These 3 Stocks Are Must-Buys3 Stocks That Wall Street Insiders Can’t Stop Buying This page (NASDAQ:REGN) was last updated on 1/20/2025 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredJanuary 29th - the next big trading catalyst to watch Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO t...Timothy Sykes | SponsoredStunning Trump Exec Order LeakedMost people have no clue this unassuming facility exists. Yet the minute Donald Trump takes office... ...Banyan Hill Publishing | SponsoredNvidia’s Bold Move: Tackling Tech’s $1 Trillion CrisisTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredMost People Are Dead Wrong.Turn on any financial news outlet at any given moment and within minutes you're guaranteed to see headlines ab...Brownstone Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Regeneron Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Regeneron Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
